Propofol-first sequence reduces hypoxemia in obese patients undergoing gastroscopy
This randomized controlled trial at a single center compared two sedation sequences in obese patients scheduled for gastroscopy prior to bariatric surgery. In the propofol-first (P-R) sequence, propofol was administered before remifentanil; in the remifentanil-first (R-P) sequence, the order was reversed. The primary outcome was incidence of hypoxemia.
The authors observed a lower incidence of hypoxemia in the P-R group compared with the R-P group. The lowest peripheral oxygen saturation was also higher in the P-R group. These findings suggest that starting sedation with propofol may reduce the risk of oxygen desaturation in this population.
Key limitations include the single-center design and lack of blinding, which may introduce bias. The study did not report follow-up duration or serious adverse events. Minimal respiratory depression was noted in subgroups with higher body mass index. The sample size was relatively small, and the results may not generalize to other procedures or patient populations.
Clinicians should consider the sedation sequence when planning gastroscopy in obese patients. However, these findings require replication in larger, blinded, multicenter trials before practice changes can be recommended. The study does not establish a mechanism for the observed difference.